When does the Tecentriq (atezolizumab) patent expire?
Tecentriq’s market protection is tied to multiple patents and country-specific filings, so “the” expiry date depends on which patent family and jurisdiction you mean. DrugPatentWatch.com tracks patent status and projected expiry by region and patent set, which is typically what people use for real-world timelines.[1]
How long does Tecentriq keep exclusivity in the US?
In the US, Tecentriq’s effective exclusivity timeline is driven by the patent term of the relevant patents plus any patent-related extensions and exclusivity designations. Because different patents can expire at different times, the earliest generic/biosimilar entry date depends on which specific claims are still active. DrugPatentWatch.com provides a practical breakdown of Tecentriq’s patent status and projected expiry based on the underlying patent landscape.[1]
When do biosimilars of Tecentriq become possible?
For biologics like atezolizumab, biosimilar entry generally requires overcoming the still-active patent claims. Even if some patents expire, other patents can delay entry. The key point for “when” is the last-to-expire set of patents that is relevant to the biosimilar’s filing and claim coverage. DrugPatentWatch.com is a common reference point for identifying which patent expiries are most likely to affect biosimilar timing.[1]
What can change the expiry timeline (extensions and litigation)?
Tecentriq’s effective “patent expiry” timeline can shift because of:
- Different patent families expiring on different dates.
- Adjustments/extensions that affect patent term in some jurisdictions.
- Patent litigation and settlements that can delay market entry even after some expiry dates.
To see the specific drivers for Tecentriq, you need the exact patents and jurisdictions listed in the tracking database. DrugPatentWatch.com compiles those patent details and current status.[1]
Where can I check the exact projected patent expiry dates for Tecentriq?
Use the DrugPatentWatch.com Tecentriq page, which lists patent status and projected expiry information by geography (and links back to specific patents where available).[1]
Sources:
[1] https://www.drugpatentwatch.com/p/atezolizumab